Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation
Interested in new trials?
Get alerts for new trials in your area by subscribing now
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
What are stem cell clinical trials?
Stem cell clinical trials are research studies that explore the therapeutic potential of stem cells for treating a wide range of diseases and conditions. These trials investigate various types of stem cells, including embryonic stem cells, induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), and adipose-derived stem cells. These trials aim to develop treatments for a wide range of conditions, such as cardiovascular diseases, neurological disorders, autoimmune diseases, orthopedic injuries, Alzheimer's disease, Crohn's disease and cancer.
Importance of clinical trials for stem cells
Clinical trials for stem cells are crucial for advancing regenerative medicine and offering hope for patients with conditions that are currently difficult to treat. These studies help to determine the safety, efficacy, and optimal use of stem cell therapies, potentially leading to breakthroughs in the treatment of chronic diseases, immune disorders, and injuries. They play a vital role in understanding how stem cells can be used to repair damaged tissues, treat malignancies, and improve patient outcomes.
Types of interventions studied in stem cells clinical trials
Stem cell clinical trials investigate a variety of interventions aimed at utilizing the unique properties of stem cells for therapeutic purposes. Some common types of interventions studied in stem cell clinical trials include:
Allogeneic and autologous stem cell transplantation
These trials assess the use of stem cells derived from both the patient (autologous) and donors (allogeneic) for the treatment of hematologic diseases, solid tumors, and immune disorders, aiming to restore normal cell function and immune response.
Cell replacement therapies
Some trials focus on using stem cells to replace or repair damaged or dysfunctional cells or tissues in the body. For example, mesenchymal stem cells (MSCs) may be used to regenerate bone, cartilage, or muscle tissue in orthopedic conditions, while hematopoietic stem cell transplants are used to replace damaged blood-forming cells in conditions such as leukemia or aplastic anemia.
Tissue engineering and regenerative medicine
Clinical trials are investigating stem cells for their potential to stimulate tissue regeneration and repair. This includes approaches such as seeding stem cells onto scaffolds or matrices to create tissue-engineered constructs for transplantation. Research includes developing bioengineered tissues and organs using stem cells to replace damaged tissues in conditions like Crohn's disease-related fistulas, cartilage defects, and chronic pancreatitis.
Gene therapy
Gene-modified stem cell therapies are being investigated for their potential in treating genetic disorders, metabolic diseases, and certain types of cancer. For example, genetically modified hematopoietic stem cells may be used to treat inherited blood disorders like sickle cell disease or beta-thalassemia.
Neuroprotection and neuroregeneration
Clinical trials are studying stem cell therapies for their potential to protect and regenerate neurons in neurodegenerative diseases and neurological injuries. This includes approaches such as transplantation of neural stem cells or mesenchymal stem cells, as well as promoting endogenous neurogenesis and synaptic repair.
Eligibility and participation in stem cells clinical trials
Eligibility for stem cells clinical trials varies widely, targeting specific diseases, age groups, and health conditions. Trials may be open to individuals with specific diagnoses, such as leukemia, Alzheimer's disease, or organ-specific injuries. Criteria often include the stage of the disease, previous treatments, and overall health status.
What to expect when participating in a stem cells clinical trial
Participants can expect thorough screening for eligibility, comprehensive information about the study's purpose and procedures, and close monitoring throughout the trial. This may involve receiving stem cell infusions, undergoing surgical procedures for tissue transplantation, and participating in follow-up assessments to monitor the therapy's effectiveness and any side effects.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
How to enroll in a stem cell clinical trial
Enrolling in a stem cell clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our search function or filters to find clinical trials that match your medical condition and interest in stem cell therapy. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.